Upcoming events

EuroPCR 2016 Highlights: Interventions for Valvular Disease and Heart Failure

Summary

Find out why the Heart Team “won” this year’s Great Debate on opening TAVI to intermediate risk patients when we join S. Windecker, B. Prendergast and D. Tchetche as they discuss one of the central themes of EuroPCR 2016. Innovation and safety are key words in state of the art in mitral valve interventions or the role interventional cardiology and certain new devices could play in the treatment of Heart Failure… Join the discussion!

This video is supported by an educational grant from  Edwards Lifesciences.

Edwards Lifesciences Logo

No comments yet!